UWA-001
UWA-001 (also known as α-phenyl-MDMA and methylenedioxymephenidine) is a phenethylamine derivative invented at the University of Western Australia as non-toxic alternative to 3,4-methylenedioxy-N-methylamphetamine (MDMA) and researched as a potential treatment for Parkinson's disease. It has a 5-HT2A receptor affinity of 1.2 μM (∼10-fold increase compared to MDMA), 1.3 μM for the serotonin transporter (∼4-fold decrease compared to MDMA), 13.4 μM for the norepinephrine transporter (∼26-fold increase compared to MDMA) and virtually no affinity for the dopamine transporter (>50 μM).
Wikipage redirect
primaryTopic
UWA-001
UWA-001 (also known as α-phenyl-MDMA and methylenedioxymephenidine) is a phenethylamine derivative invented at the University of Western Australia as non-toxic alternative to 3,4-methylenedioxy-N-methylamphetamine (MDMA) and researched as a potential treatment for Parkinson's disease. It has a 5-HT2A receptor affinity of 1.2 μM (∼10-fold increase compared to MDMA), 1.3 μM for the serotonin transporter (∼4-fold decrease compared to MDMA), 13.4 μM for the norepinephrine transporter (∼26-fold increase compared to MDMA) and virtually no affinity for the dopamine transporter (>50 μM).
has abstract
UWA-001 (also known as α-pheny ...... as a NMDA receptor antagonist.
@en
CAS number
1350821-28-1
ChEMBL
PubChem
Wikipage page ID
49,055,444
page length (characters) of wiki page
Wikipage revision ID
1,011,066,503
Link from a Wikipage to another Wikipage
CAS number
ChEMBL
ChemSpiderID
34,245,583
IUPAC name
PubChem
17,757,315
SMILES
CNCc3ccccc3
@en
StdInChIKey
DNOTUUOUOFJQJC-UHFFFAOYSA-N
@en
wikiPageUsesTemplate
subject
hypernym
comment
UWA-001 (also known as α-pheny ...... dopamine transporter (>50 μM).
@en
label
UWA-001
@en